Risperidone significantly inhibits interferon-gamma-induced microglial activation in vitro
- PMID: 17363222
- DOI: 10.1016/j.schres.2007.01.019
Risperidone significantly inhibits interferon-gamma-induced microglial activation in vitro
Abstract
Microglia has recently been regarded to be a mediator of neuroinflammation via the release of proinflammatory cytokines, nitric oxide (NO) and reactive oxygen species (ROS) in the central nervous system (CNS). Microglia has thus been reported to play an important role in the pathology of neurodegenerative disease, such as Alzheimer's disease (AD) and Parkinson's disease (PD). The pathological mechanisms of schizophrenia remain unclear while some recent neuroimaging studies suggest even schizophrenia may be a kind of neurodegenerative disease. Risperidone has been reported to decrease the reduction of MRI volume during the clinical course of schizophrenia. Many recent studies have demonstrated that immunological mechanisms via such as interferon (IFN)-gamma and cytokines might be relevant to the pathophysiology of schizophrenia. In the present study, we thus investigated the effects of risperidone on the generation of nitric oxide, inducible NO synthase (iNOS) expression and inflammatory cytokines: interleukin (IL)-1beta, IL-6 and tumor necrosis factor (TNF)-alpha by IFN-gamma-activated microglia by using Griess assay, Western blotting and ELISA, respectively. In comparison with haloperidol, risperidone significantly inhibited the production of NO and proinflammatory cytokines by activated microglia. The iNOS levels of risperidone-treated cells were much lower than those of the haloperidol-treated cells. Antipsychotics, especially risperidone may have an anti-inflammatory effect via the inhibition of microglial activation, which is not only directly toxic to neurons but also has an inhibitory effect on neurogenesis and oligodendrogenesis, both of which have been reported to play a crucial role in the pathology of schizophrenia.
Similar articles
-
Minocycline and antipsychotics inhibit inflammatory responses in BV-2 microglia activated by LPS via regulating the MAPKs/ JAK-STAT signaling pathway.BMC Psychiatry. 2023 Jul 18;23(1):514. doi: 10.1186/s12888-023-05014-1. BMC Psychiatry. 2023. PMID: 37464316 Free PMC article.
-
Interleukin-6-induced S100B secretion is inhibited by haloperidol and risperidone.Prog Neuropsychopharmacol Biol Psychiatry. 2013 Jun 3;43:14-22. doi: 10.1016/j.pnpbp.2012.12.001. Epub 2012 Dec 13. Prog Neuropsychopharmacol Biol Psychiatry. 2013. PMID: 23246638
-
Inhibitory effects of aripiprazole on interferon-gamma-induced microglial activation via intracellular Ca2+ regulation in vitro.J Neurochem. 2008 Jul;106(2):815-25. doi: 10.1111/j.1471-4159.2008.05435.x. Epub 2008 Apr 19. J Neurochem. 2008. PMID: 18429930
-
Anti-Inflammatory properties of antipsychotics via microglia modulations: are antipsychotics a 'fire extinguisher' in the brain of schizophrenia?Mini Rev Med Chem. 2011 Jun;11(7):565-74. doi: 10.2174/138955711795906941. Mini Rev Med Chem. 2011. PMID: 21699487 Review.
-
Identification of new therapeutic _targets for prevention of CNS inflammation.Expert Opin Ther _targets. 2002 Apr;6(2):203-15. doi: 10.1517/14728222.6.2.203. Expert Opin Ther _targets. 2002. PMID: 12223081 Review.
Cited by
-
Repurposing psychiatric medicines to _target activated microglia in anxious mild cognitive impairment and early Parkinson's disease.Am J Neurodegener Dis. 2016 Mar 1;5(1):29-51. eCollection 2016. Am J Neurodegener Dis. 2016. PMID: 27073741 Free PMC article. Review.
-
High-throughput screening discovers antifibrotic properties of haloperidol by hindering myofibroblast activation.JCI Insight. 2019 Apr 18;4(8):e123987. doi: 10.1172/jci.insight.123987. eCollection 2019 Apr 18. JCI Insight. 2019. PMID: 30996132 Free PMC article.
-
Antioxidant Properties of Second-Generation Antipsychotics: Focus on Microglia.Pharmaceuticals (Basel). 2020 Dec 12;13(12):457. doi: 10.3390/ph13120457. Pharmaceuticals (Basel). 2020. PMID: 33322693 Free PMC article. Review.
-
Inflammation in patients with schizophrenia: the therapeutic benefits of risperidone plus add-on dextromethorphan.J Neuroimmune Pharmacol. 2012 Sep;7(3):656-64. doi: 10.1007/s11481-012-9382-z. Epub 2012 Jun 23. J Neuroimmune Pharmacol. 2012. PMID: 22730040 Free PMC article. Clinical Trial.
-
The Role of Total White Blood Cell Count in Antipsychotic Treatment for Patients with Schizophrenia.Curr Neuropharmacol. 2024;22(1):159-167. doi: 10.2174/1570159X21666230104090046. Curr Neuropharmacol. 2024. PMID: 36600620 Free PMC article. Clinical Trial.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources